{"url_path":"/sec/ipsc/proxy/2026-04-27/000110465926049493","section_key":"body","section_title":"DEFA14A body","topic":"sec","document":{"doc_type":"DEFA14A","doc_date":"2026-04-27","source_url":"https://www.sec.gov/Archives/edgar/data/1850119/0001104659-26-049493-index.html","accession_number":"0001104659-26-049493","cik":"0001850119","ticker":"IPSC","issuer_name":"Century Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1850119/0001104659-26-049493-index.html","primary_entity_key":"0001850119","primary_entity_name":"Century Therapeutics, Inc."},"word_count":139,"has_tables":true,"body_markdown":"DEFA14A\n1\ntm261507d3_defa14a.htm\nDEFA14A\n\n**UNITED STATES**\n\n**SECURITIES AND EXCHANGE COMMISSION**\n\n**Washington, D.C. 20549**\n\n**SCHEDULE 14A**\n\n**Proxy Statement Pursuant to Section 14(a) of**\n\n**the Securities Exchange Act of 1934 (Amendment\nNo. )**\n\nFiled by the Registrant x\n\nFiled by a Party other than the Registrant ¨\n\nCheck the appropriate box:\n\n¨\nPreliminary Proxy Statement\n\n¨\n**Confidential, for Use of the Commission Only (as\npermitted by Rule 14a-6(e)(2))**\n\n¨\nDefinitive Proxy Statement\n\nx\nDefinitive Additional Materials\n\n¨\nSoliciting Material under §240.14a-12\n\n**CENTURY\nTHERAPEUTICS, INC.**\n\n(Name of Registrant as Specified in Its Charter)\n\n(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)\n\nPayment of Filing Fee (Check all boxes\nthat apply):\n\nx\nNo fee required\n\n¨\nFee paid previously with preliminary materials\n\n¨\nFee computed on table in exhibit required by Item 25(b) per\nExchange Act Rules 14a-6(i)(1) and 0-11"}